Showing results (121-130 of 127) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Translational Lung Cancer Research|May 19, 2025
Development and validation of machine learning models based on molecular features for estimating the probability of multiple primary lung carcinoma versus intrapulmonary metastasis in patients presenting multiple non-small cell lung cancersNing Liu, Xue Li, Xu Luo, et al.Journal of Medicinal Chemistry|March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo ActivityLaurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.The Journal of Pharmacology and Experimental Therapeutics|April 19, 2008
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in ratsSonya G Lehto, Rami Tamir, Hong Deng, et al.Journal of Medicinal Chemistry|March 7, 2014
Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel B Horne, Nuria A Tamayo, Michael D Bartberger, et al.The Journal of Pharmacology and Experimental Therapeutics|July 27, 2007
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockadeNarender R Gavva, Anthony W Bannon, David N Hovland, et al.Cell|May 8, 2026
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancersYiyun Wang, Ailing Zhong, Bo Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 2025
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancerManli Wang, Yiyun Wang, Xiangyu Pan, et al.Pageof 13